Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 8,086,000 | 8,157,000 | 8,663,000 | 9,240,000 | 9,117,000 |
| Cost of Goods | 2,673,000 | 2,539,000 | 2,874,000 | 2,880,000 | 2,728,000 |
| Gross Profit | 5,413,000 | 5,618,000 | 5,789,000 | 6,360,000 | 6,389,000 |
| Operating Expenses | 4,118,000 | 4,029,000 | 4,246,000 | 4,060,000 | 4,503,000 |
| Operating Income | 1,295,000 | 1,589,000 | 1,543,000 | 2,300,000 | 1,886,000 |
| Interest Expense | 154,000 | 157,000 | 146,000 | 186,000 | 181,000 |
| Other Income | -594,000 | -88,000 | -1,146,000 | -80,000 | -250,000 |
| Pre-tax Income | 547,000 | 1,344,000 | 251,000 | 2,034,000 | 1,455,000 |
| Income Tax | 48,000 | 311,000 | -197,000 | 456,000 | 367,000 |
| Net Income Continuous | 492,000 | 1,044,000 | 438,000 | 1,577,000 | 1,203,000 |
| Minority Interests | -44,000 | -40,000 | -28,000 | -38,000 | -50,000 |
| Net Income | $448,000 | $1,004,000 | $410,000 | $1,539,000 | $1,153,000 |
| EPS Basic Total Ops | 0.34 | 0.76 | 0.31 | 1.17 | 0.88 |
| EPS Basic Continuous Ops | 0.34 | 0.76 | 0.31 | 1.17 | 0.88 |
| EPS Diluted Total Ops | 0.34 | 0.76 | 0.31 | 1.17 | 0.88 |
| EPS Diluted Continuous Ops | 0.34 | 0.76 | 0.31 | 1.17 | 0.88 |
| EBITDA(a) | $1,469,000 | $2,276,000 | $1,197,000 | $3,036,000 | $2,478,000 |